The US pharmaceutical group is to trial its coronavirus vaccine candidate phase 3 in the UK
Financial Times report:
- UK trial
- 6,000 UK volunteers on a two-dose basis in a phase 3 trial
If successful the next step would be to approach regulators for approval.
FT link for moe (may be gated)
The second global Phase 3 clinical trial of Janssen COVID-19 vaccine candidate
